1. By how much does AF increase the risk of ischemic stroke across all age groups

2. What is the most common form of AF in elderly patients?

3. Compared with younger patients, elderly patients with AF are typically:

4. Which of the following is the only risk factor for stroke that earns 2 points on the CHADS2 risk score?

5. Which of the following risk factors is assessed by the CHA2DS2-VASc score, but not the CHADS2 score?

6. What is the most commonly reported reason for withholding anticoagulation in patients with AF?

7. Which of the following HAS-BLED scores indicates an increased risk for bleeding during anticoagulation?

8. Which of the following anticoagulants requires routine INR monitoring?

9. Storage and handling recommendations have been published for which of the following new anticoagulants?

10. Rivaroxaban is NOT recommended for use in which patient group, defined by CrCl?

11. In a 2011 ACC/AHA guideline update for the management of AF, which of the following was mentioned as an alternative to aspirin or warfarin for the prevention of stroke or systemic embolism?

12. To facilitate medication reconciliation during care transitions, which of the following should be documented in patients receiving anticoagulation for stroke prevention in AF?

Evaluation Questions

13. CASE: Mr. James is a 78-year-old male patient residing in long-term care who was recently diagnosed with new onset paroxysmal, non-valvular atrial fibrillation (AF). He is hypertensive with a history of previous myocardial infarction, and he was diagnosed with diabetes mellitus six months earlier. What is this patient's stroke risk score according to the CHA2DS2 VASc risk scoring system?

14. Based on his stroke risk, what do 2011 ACCF/AHA/HRS guideline updates recommend for therapy?

15. Oral anticoagulants are largely underused in elderly patients at risk for stroke from AF.

16. Properties of Factor Xa inhibitors currently in development for prevention of stroke and systemic embolism in patients with non-valvular AF include all of the following except:

17. In your practice, approximately what percentages of elderly patients with atrial fibrillation currently undergo stroke risk scoring assessments?

18. In your practice, approximately what percentage of elderly patients with atrial fibrillation and higher stroke risk are NOT currently receiving anticoagulation therapy?

19. Which of the following drugs is NOT documented as having interactions with warfarin?

« Return to Activity